Sridhar Nimmagadda

2024

CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

Sharma, A. K., Gupta, K., Mishra, A., Lofland, G., Marsh, I., Kumar, D., Ghiaur, G., Imus, P., Rowe, S. P., Hobbs, R. F., Gocke, C. B. & Nimmagadda, S., 2024, (Accepted/In press) In: Advanced Science.

Research output: Contribution to journal › Article › peer-review

Open Access

Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia

Vu, T. T., Kim, K., Manna, M., Thomas, J., Remaily, B. C., Montgomery, E. J., Costa, T., Granchie, L., Xie, Z., Guo, Y., Chen, M., Castillo, A. M. M., Kulp, S. K., Mo, X., Nimmagadda, S., Gregorevic, P., Owen, D. H., Ganesan, L. P., Mace, T. A., Coss, C. C., & 1 othersPhelps, M. A., Jan 2024, In: Pharmacological Research. 199, 107048.

Research output: Contribution to journal › Article › peer-review

Open Access

Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1

Ludwig, S. D., Meksiriporn, B., Tan, J., Kureshi, R., Mishra, A., Kaeo, K. J., Zhu, A., Stavrakis, G., Lee, S. J., Schodt, D. J., Wester, M. J., Lidke, K. A., Cox, A., Dooley, H. M., Nimmagadda, S. & Spangler, J. B., 2024, (Accepted/In press) In: Cell Chemical Biology.

Research output: Contribution to journal › Article › peer-review

PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract Cancers

Oldan, J. D., Schroeder, J. A., Hoffman-Censits, J., Rathmell, W. K., Milowsky, M. I., Solnes, L. B., Nimmagadda, S., Gorin, M. A., Khandani, A. H. & Rowe, S. P., Apr 2024, In: PET Clinics. 19, 2, p. 197-206 10 p.

Research output: Contribution to journal › Review article › peer-review

2023

An optimized radiosynthesis of [¹⁸F]DK222, a PET radiotracer for imaging PD-L1

Holt, D. P., Kumar, D., Nimmagadda, S. & Dannals, R. F., Feb 2023, In: Journal of Labelled Compounds and Radiopharmaceuticals. 66, 2, p. 47-54 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with ⁸⁹Zirconium oxine for PET imaging

Leland, P., Kumar, D., Nimmagadda, S., Bauer, S. R., Puri, R. K. & Joshi, B. H., Dec 2023, In: Journal of translational medicine. 21, 1, 367.

Research output: Contribution to journal › Article › peer-review

Open Access

Correction: Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with ⁸⁹Zirconium oxine for PET imaging (Journal of Translational Medicine, (2023), 21, 1, (367), 10.1186/s12967-023-04142-2)

Leland, P., Kumar, D., Nimmagadda, S., Bauer, S. R., Puri, R. K. & Joshi, B. H., Dec 2023, In: Journal of translational medicine. 21, 1, 636.

Research output: Contribution to journal › Comment/debate › peer-review

Open Access

Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics

Mishra, A., Kumar, D., Gupta, K., Lofland, G., Sharma, A. K., Banka, D. S., Hobbs, R. F., Dannals, R. F., Rowe, S. P., Gabrielson, E. & Nimmagadda, S., Feb 1 2023, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 29, 3, p. 581-591 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Non-invasive PD-L1 quantification using [ 18 F]DK222-PET imaging in cancer immunotherapy

Mishra, A., Gupta, K., Kumar, D., Lofland, G., Sharma, A. K., Solnes, L. B., Rowe, S. P., Forde, P. M., Pomper, M. G., Gabrielson, E. W. & Nimmagadda, S., Oct 4 2023, In: Journal for immunotherapy of cancer. 11, 10, e007535.

Research output: Contribution to journal › Article › peer-review

Open Access

PET/MRI and Bioluminescent Imaging Identify Hypoxia as a Cause of Programmed Cell Death Ligand 1 Image Heterogeneity

Parkins, K. M., Krishnamachary, B., Jacob, D., Kakkad, S. M., Solaiyappan, M., Mishra, A., Mironchik, Y., Penet, M. F., McMahon, M. T., Knopf, P., Pichler, B. J., Nimmagadd, S. & Bhujwalla, Z. M., Jul 2023, In: Radiology: Imaging Cancer. 5, 4, e220138.

Research output: Contribution to journal › Article › peer-review

Open Access

2022

First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients

Zhou, X., Jiang, J., Yang, X., Liu, T., Ding, J., Nimmagadda, S., Pomper, M. G., Zhu, H., Zhao, J., Yang, Z. & Li, N., Apr 1 2022, In: Journal of Nuclear Medicine. 63, 4, p. 536-542 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Imaging PD-L1 expression in melanoma brain metastases

Nimmagadda, S., Jun 1 2022, In: Journal of Nuclear Medicine. 63, 6

Research output: Contribution to journal › Article › peer-review

Open Access

PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model

Jin, J., Sivakumar, I., Mironchik, Y., Krishnamachary, B., Wildes, F., Barnett, J. D., Hung, C. F., Nimmagadda, S., Kobayashi, H., Bhujwalla, Z. M. & Penet, M. F., Feb 1 2022, In: Cancers. 14, 3, 619.

Research output: Contribution to journal › Article › peer-review

Open Access

2021

Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules

Slania, S. L., Das, D., Lisok, A., Du, Y., Jiang, Z., Mease, R. C., Rowe, S. P., Nimmagadda, S., Yang, X. & Pomper, M. G., Apr 8 2021, In: Journal of medicinal chemistry. 64, 7, p. 4059-4070 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics

Kumar, D., Mishra, A., Lisok, A., Kureshi, R., Shelake, S., Plyku, D., Sen, R., Doucet, M., De Silva, R. A., Mease, R. C., Forde, P. M., Jaffee, E. M., Desai, P., Ganguly, S., Gabrielson, E., Vaidya, D., Spangler, J. B. & Nimmagadda, S., Sep 14 2021, In: Proceedings of the National Academy of Sciences of the United States of America. 118, 37, e2107982118.

Research output: Contribution to journal › Article › peer-review

Open Access

Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [¹¹¹In]In-XYIMSR-01 for phase I regulatory approval

De Silva, R. A., Gorin, M. A., Mease, R. C., Minn, I., Lisok, A., Plyku, D., Nimmagadda, S., Allaf, M. E., Yang, X., Sgouros, G., Rowe, S. P. & Pomper, M. G., May 30 2021, In: Journal of Labelled Compounds and Radiopharmaceuticals. 64, 6, p. 243-250 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2020

Comparison of skeletal and soft tissue pericytes identifies CXCR4⁺ bone forming mural cells in human tissues

Xu, J., Li, D., Hsu, C. Y., Tian, Y., Zhang, L., Wang, Y., Tower, R. J., Chang, L., Meyers, C. A., Gao, Y., Broderick, K., Morris, C. D., Hooper, J., Nimmagadda, S., Péault, B. & James, A. W., Dec 1 2020, In: Bone Research. 8, 1, 22.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [¹²⁴I]FIAU PET/CT

Cho, S. Y. H., Rowe, S. P., Jain, S. K., Schon, L. C., Yung, R. C., Nayfeh, T. A., Bingham, C. O., Foss, C. A., Nimmagadda, S. & Pomper, M. G., 2020, In: Molecular imaging. 19

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

Ovarian Cancer Targeted Theranostics

Nimmagadda, S. & Penet, M. F., Jan 21 2020, In: Frontiers in Oncology. 9, 1537.

Research output: Contribution to journal › Review article › peer-review

Open Access

8 Scopus citations

Quantifying pd-l1 expression to monitor immune checkpoint therapy: Opportunities and challenges

Nimmagadda, S., Nov 2020, In: Cancers. 12, 11, p. 1-26 26 p., 3173.

Research output: Contribution to journal › Review article › peer-review

Open Access

1 Scopus citations

2019

Development of [¹⁸F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide

Lesniak, W. G., Mease, R. C., Chatterjee, S., Kumar, D., Lisok, A., Wharram, B., Kalagadda, V. R., Emens, L. A., Pomper, M. G. & Nimmagadda, S., Jun 11 2019, In: Molecular imaging. 18

Research output: Contribution to journal › Article › peer-review

Open Access

17 Scopus citations

Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer

Lesniak, W. G., Boinapally, S., Banerjee, S. R., Behnam Azad, B., Foss, C. A., Shen, C., Lisok, A., Wharram, B., Nimmagadda, S. & Pomper, M. G., Jun 3 2019, In: Molecular Pharmaceutics. 16, 6, p. 2590-2604 15 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells

Jin, J., Krishnamachary, B., Barnett, J. D., Chatterjee, S., Chang, D., Mironchik, Y., Wildes, F., Jaffee, E. M., Nimmagadda, S. & Bhujwalla, Z. M., Feb 27 2019, In: ACS Applied Materials and Interfaces. 11, 8, p. 7850-7861 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

37 Scopus citations

Peptide-based PET quantifies target engagement of PD-L1 therapeutics

Kumar, D., Lisok, A., Dahmane, E., McCoy, M., Shelake, S., Chatterjee, S., Allaj, V., Sysa-Shah, P., Wharram, B., Lesniak, W. G., Tully, E., Gabrielson, E., Jaffee, E. M., Poirier, J. T., Rudin, C. M., Gobburu, J. V. S., Pomper, M. G. & Nimmagadda, S., Feb 1 2019, In: Journal of Clinical Investigation. 129, 2, p. 616-630 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

31 Scopus citations

Preclinical Experimentation in Oncology

Nimmagadda, S., Shelake, S. & Pomper, M. G., Jan 1 2019, Radiopharmaceutical Chemistry. Springer International Publishing, p. 569-582 14 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

SNP2SIM: A modular workflow for standardizing molecular simulation and functional analysis of protein variants

McCoy, M. D., Shivakumar, V., Nimmagadda, S., Jafri, M. S. & Madhavan, S., Apr 3 2019, In: BMC Bioinformatics. 20, 1, 171.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

2018

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

Ravi, R., Noonan, K. A., Pham, V., Bedi, R., Zhavoronkov, A., Ozerov, I. V., Makarev, E., Artemov, A. V., Wysocki, P. T., Mehra, R., Nimmagadda, S., Marchionni, L., Sidransky, D., Borrello, I. M., Izumchenko, E. & Bedi, A., Dec 1 2018, In: Nature communications. 9, 1, 741.

Research output: Contribution to journal › Article › peer-review

Open Access

95 Scopus citations

Immune modulation therapy and imaging: Workshop report

Shields, A. F., Jacobs, P. M., Sznol, M., Graham, M. M., Germain, R. N., Lum, L. G., Jaffee, E. M., De Vries, E. G. E., Nimmagadda, S., Van Den Abbeele, A. D., Leung, D. K., Wu, A. M., Sharon, E. & Shankar, L. K., Mar 1 2018, In: Journal of Nuclear Medicine. 59, 3, p. 410-417 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

14 Scopus citations

Low-level endogenous PSMA expression in nonprostatic tumor xenografts is sufficient for in vivo tumor targeting and imaging

Nimmagadda, S., Pullambhatla, M., Chen, Y., Parsana, P., Lisok, A., Chatterjee, S., Mease, R., Rowe, S. P., Lupold, S., Pienta, K. J. & Pomper, M. G., Mar 1 2018, In: Journal of Nuclear Medicine. 59, 3, p. 486-493 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

Molecular Imaging of CXCL12 Promoter-driven HSV1-TK Reporter Gene Expression

Alon, L., Kraitchman, D. L., Schär, M., Cortez, A., Yadav, N. N., Krimins, R., Johnston, P. V., McMahon, M. T., van Zijl, P. C. M., Nimmagadda, S., Pomper, M. G., Bulte, J. W. M. & Gilad, A. A., Mar 1 2018, In: Biotechnology and Bioprocess Engineering. 23, 2, p. 208-217 10 p.

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Peptide-Based ⁶⁸ Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer

De Silva, R. A., Kumar, D., Lisok, A., Chatterjee, S., Wharram, B., Venkateswara Rao, K., Mease, R., Dannals, R. F., Pomper, M. G. & Nimmagadda, S., Sep 4 2018, In: Molecular Pharmaceutics. 15, 9, p. 3946-3952 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

35 Scopus citations

2017

A PSMA-targeted theranostic agent for photodynamic therapy

Chen, Y., Chatterjee, S., Lisok, A., Minn, I., Pullambhatla, M., Wharram, B., Wang, Y., Jin, J., Bhujwalla, Z. M., Nimmagadda, S., Mease, R. C. & Pomper, M. G., Feb 1 2017, In: Journal of Photochemistry and Photobiology B: Biology. 167, p. 111-116 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

26 Scopus citations

Corrigendum to “Rapid PD-L1 detection in tumors with PET using a highly specific peptide” [Biochemical and Biophysical Research Communications 483/1 (2017) 258–263] (S0006291X16322161) (10.1016/j.bbrc.2016.12.156)

Chatterjee, S., Lesniak, W. G., Miller, M. S., Lisok, A., Sikorska, E., Wharram, B., Kumar, D., Gabrielson, M., Pomper, M., Gabelli, S. B. & Nimmagadda, S., Sep 30 2017, In: Biochemical and Biophysical Research Communications. 491, 4, p. 1125 1 p.

Research output: Contribution to journal › Comment/debate › peer-review

Open Access

2 Scopus citations

Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry

Zlitni, A., Yin, M., Janzen, N., Chatterjee, S., Lisok, A., Gabrielson, K. L., Nimmagadda, S., Pomper, M. G., Foster, F. S. & Valliant, J. F., May 2017, In: PloS one. 12, 5, 0176958.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: Implications for assessment by small biopsy

Gniadek, T. J., Li, Q. K., Tully, E., Chatterjee, S., Nimmagadda, S. & Gabrielson, E., Apr 1 2017, In: Modern Pathology. 30, 4, p. 530-538 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

63 Scopus citations

Imaging α4β2 Nicotinic Acetylcholine Receptors (nAChRs) in Baboons with [¹⁸F]XTRA, a Radioligand with Improved Specific Binding in Extra-Thalamic Regions

Kuwabara, H., Gao, Y., Stabin, M., Coughlin, J., Nimmagadda, S., Dannals, R. F., Pomper, M. G. & Horti, A. G., Apr 1 2017, In: Molecular Imaging and Biology. 19, 2, p. 280-288 9 p.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

In vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent

Lesniak, W. G., Aboye, T., Chatterjee, S., Camarero, J. A. & Nimmagadda, S., Oct 17 2017, In: Chemistry - A European Journal. 23, 58, p. 14469-14475 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy

Chatterjee, S., Lesniak, W. G. & Nimmagadda, S., Jul 5 2017, In: Molecular imaging. 16

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

Rapid PD-L1 detection in tumors with PET using a highly specific peptide

Chatterjee, S., Lesniak, W. G., Miller, M. S., Lisok, A., Sikorska, E., Wharram, B., Kumar, D., Gabrielson, M., Pomper, M., Gabelli, S. B. & Nimmagadda, S., Jan 29 2017, In: Biochemical and Biophysical Research Communications. 483, 1, p. 258-263 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

72 Scopus citations

2016

[⁶⁴Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma

Minn, I., Koo, S. M., Lee, H. S., Brummet, M., Rowe, S. P., Gorin, M. A., Sysa-Shah, P., Lewis, W. D., Ahn, H. H., Wang, Y., Banerjee, S. R., Mease, R. C., Nimmagadda, S., Allaf, M. E., Pomper, M. G. & Yang, X., 2016, In: Oncotarget. 7, 35, p. 56471-56479 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

29 Scopus citations

A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts

Azad, B. B., Chatterjee, S., Lesniak, W. G., Lisok, A., Pullambhatla, M., Bhujwalla, Z. M., Pomper, M. G. & Nimmagadda, S., Mar 15 2016, In: Oncotarget. 7, 11, p. 12344-12358 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

23 Scopus citations

A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors

Chatterjee, S., Lesniak, W. G., Gabrielson, M., Lisok, A., Wharram, B., Sysa-Shah, P., Azad, B. B., Pomper, M. G. & Nimmagadda, S., 2016, In: Oncotarget. 7, 9, p. 10215-10227 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

96 Scopus citations

Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)

Yang, X., Mease, R. C., Pullambhatla, M., Lisok, A., Chen, Y., Foss, C. A., Wang, Y., Shallal, H., Edelman, H., Hoye, A. T., Attardo, G., Nimmagadda, S. & Pomper, M. G., Jan 14 2016, In: Journal of medicinal chemistry. 59, 1, p. 206-218 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

25 Scopus citations

PD-L1 Detection in Tumors Using [⁶⁴Cu]Atezolizumab with PET

Lesniak, W. G., Chatterjee, S., Gabrielson, M., Lisok, A., Wharram, B., Pomper, M. & Nimmagadda, S., Sep 21 2016, In: Bioconjugate Chemistry. 27, 9, p. 2103-2110 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

79 Scopus citations

Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform

Lesniak, W. G., Oskolkov, N., Song, X., Lal, B., Yang, X., Pomper, M., Laterra, J., Nimmagadda, S. & McMahon, M. T., Apr 13 2016, In: Nano Letters. 16, 4, p. 2248-2253 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors

Singh, A., Venkannagari, S., Oh, K. H., Zhang, Y. Q., Rohde, J. M., Liu, L., Nimmagadda, S., Sudini, K., Brimacombe, K. R., Gajghate, S., Ma, J., Wang, A., Xu, X., Shahane, S. A., Xia, M., Woo, J., Mensah, G. A., Wang, Z., Ferrer, M., Gabrielson, E., & 5 othersLi, Z., Rastinejad, F., Shen, M., Boxer, M. B. & Biswal, S., Nov 18 2016, In: ACS chemical biology. 11, 11, p. 3214-3225 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

166 Scopus citations

Targeted imaging of the atypical chemokine receptor 3 (ACKR3/CXCR7) in human cancer xenografts

Azad, B. B., Lisok, A., Chatterjee, S., Poirier, J. T., Pullambhatla, M., Luker, G. D., Pomper, M. G. & Nimmagadda, S., Jun 1 2016, In: Journal of Nuclear Medicine. 57, 6, p. 981-988 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

21 Scopus citations

2015

Imaging of carbonic anhydrase IX with an ¹¹¹In-labeled dual-motif inhibitor

Yang, X., Minn, I., Rowe, S. P., Banerjee, S. R., Gorin, M. A., Brummet, M., Lee, H. S., Koo, S. M., Sysa-Shah, P., Mease, R. C., Nimmagadda, S., Allaf, M. E. & Pomper, M. G., 2015, In: Oncotarget. 6, 32, p. 33733-33742 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

32 Scopus citations

Preclinical evaluation of ⁸⁶Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates

Banerjee, S. R., Foss, C. A., Pullambhatla, M., Wang, Y., Srinivasan, S., Hobbs, R. F., Baidoo, K. E., Brechbiel, M. W., Nimmagadda, S., Mease, R. C., Sgouros, G. & Pomper, M. G., Apr 1 2015, In: Journal of Nuclear Medicine. 56, 4, p. 628-634 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

23 Scopus citations

Prostate-specific membrane antigen as a target for cancer imaging and therapy

Kiess, A. P., Banerjee, S. R., Mease, R. C., Rowe, S. P., Rao, A., Foss, C. A., Chen, Y., Yang, X., Cho, S. Y., Nimmagadda, S. & Pomper, M. G., Sep 1 2015, In: Quarterly Journal of Nuclear Medicine and Molecular Imaging. 59, 3, p. 241-268 28 p.

Research output: Contribution to journal › Review article › peer-review

89 Scopus citations

Sridhar Nimmagadda

Research output

Search results